If someone has run amylin analogue mechanism properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Topic summary
Amylin analogue mechanism: satiety signalling separate from GLP-1
This is a generated summary. It shows the 9 most-liked posts from a topic of 143, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
r.erdogan, post #19: Following this. I have the same question and no better information than the first post. Go to post
Post #48 answers the question as asked. The question underneath it is different.
Summarising the amylin analogue mechanism thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the rest is people agreeing at length.
Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The hypothesis behind combination is two complementary satiety mechanisms with one injection.
30 likes 17mo
ni.kravchenko, post #59: Useful. I had the fact and not the reason, which turns out to be the important half. Go to post
Where I part company with post #68, and it is a narrow parting.
An update on my earlier amylin analogue mechanism post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
m.ekstrom, post #31: Careful with the language on amylin analogue mechanism. "Not detected" and "not present" are different findings and the first is a statement about the method. Go to post
Thank you for taking the time. That was more work than a reply usually is.
coldchain_liu, post #54: One more thing on amylin analogue mechanism that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears. Go to post
Second this, and I would have said it less carefully.
bench_notes, post #18: Noted, and thank you for writing it out rather than summarising it. Go to post
Taking post #128 at face value and following it one step further.
Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that requires a designed experiment to support it. The combination works, but the mechanism is unsettled.
The rule of thumb is fine; the edge cases are where it earns its keep.
Rodrigues, post #60: I read the earlier replies on amylin analogue mechanism twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected. Go to post
Adding the measurement that post #133 says would settle it.
Small correction to my own earlier position on amylin analogue mechanism. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely.
Read the full topic (143 posts)
This topic was referenced in
- Follow-up: What is genuinely unknown about long-term amylin agonismCompounds › Cagrilintide & amylin analogues · 2 replies
- Second pass at: Reading a combination trial: attributing effect to componentsCompounds › Cagrilintide & amylin analogues · 43 replies
Moved from Retatrutide by t.vasquez. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: Is "synergy" the right word for the combination data?
Is "synergy" the right word for the combination data? I have a specific reason for asking rather than idle curiosity, and the context is below. Putting the numbers in the first post, because a question about…
|
2 | 41k | 14mo | |
|
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1
On the subject in the title: Amylin analogue mechanism: satiety signalling separate from GLP-1 Working notes rather than a conclusion. Trying to work out what would count as evidence on Amylin analogue…
|
+27 | 31 | 671 | 12mo |
|
The CagriSema phase 2 paper and what a fixed combination buys
Posting this under the heading it deserves: The CagriSema phase 2 paper and what a fixed combination buys Everything below is what sits behind that. Working notes on cagrisema phase 2 paper rather than a…
|
+88 | 93 | 29k | 11mo |
|
What is genuinely unknown about long-term amylin agonism
What is genuinely unknown about long-term amylin agonism — that is the question, and I have not found it answered plainly anywhere I have looked. A comparison question rather than a question about one…
|
+83 | 91 | 46k | 1d |
|
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins
Amylin and gastric emptying: overlapping mechanisms with incretins — setting out what I have, and where I think it stops being reliable. A question about Amylin and gastric emptying that I think has a…
|
+21 | 25 | 44k | 5mo |
Related topics — sharing the tags effect size, randomised trial, cagrilintide
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What we do not know about retatrutide, listed explicitly
The question in the title: What we do not know about retatrutide, listed explicitly I will give what I have already checked below so nobody repeats it. Setting out what I think I know about this compound and…
|
+106 | 113 | 4.8k | 17mo |
|
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction
The question in the title: Why a glucagon receptor agonist in a weight-loss compound is not a contradiction I will give what I have already checked below so nobody repeats it. I would like to disagree…
|
+43 | 47 | 19k | 2d |
|
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small
Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on…
|
2 | 17k | 6h | |
|
Tirzepatide molecular mass and the charge states you would expect on ESI — does this still hold?
Asking directly, because I could not find a straight answer: Tirzepatide molecular mass and the charge states you would expect on ESI — does this still hold? The question about Tirzepatide molecular mass that…
|
+7 | 11 | 281 | 6mo |
|
Coming back to: Sample size calculations, read backwards from the published number
On the subject in the title: Sample size calculations, read backwards from the published number Working notes rather than a conclusion. Sample size calculations — I have the observation and I do not trust my…
|
+82 | 88 | 1.8k | 11mo |